Abnormalities of the extracellular matrix in keratoconus corneas

Cornea

Volumn 16, Issue 3, 1997, Pages 345-351

  Kenney, M C ^a,d   Nesburn, A B ^a   Burgeson, R E ^b   Butkowski, R J ^c   Ljubimov, A V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c INCSTAR Corp ^*  (United States)

^d Ophthalmology Research   (United States)

Author keywords

Basement membrane; Collagens; Cornea; Extracellular matrix; Fibrillin; Keratoconus; Laminins; Tenascin

Indexed keywords

COLLAGEN TYPE 4; COLLAGEN TYPE 7; COLLAGEN TYPE 8; ENTACTIN; FIBRILLIN; FIBRONECTIN; LAMININ; PERLECAN; TENASCIN;

ADULT; ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATOCONUS; MALE; PRIORITY JOURNAL;

EID: 0030994698     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199705000-00016     Document Type: Article

References (48)

1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol 1984;28:293-22.
2. Ihalainen A. Clinical and epidemiological features of keratoconus genetic and external factors in the pathogenesis of the disease. Acta Ophthalmol 1986;(suppl 178):5-64.
3. Mamalis N, Anderson C, Kreisler K, Lundergan M, Olson R. Changing trends in the indications for penetrating keratoplasty. Arch Ophthalmol 1992;110:1409-11.
4. Pouliquen Y. Doyne lecture keratoconus. Eye 1987;1:1-14.
5. Teng CC. Electron microscopic study of the pathology of keratoconus: part I. Am J Ophthalmol 1963;55:18-47.
6. Jakus MA. Further observations on the fine structure of the cornea. Invest Ophthalmol Vis Sci 1962;35:202-25.
7. Bron AJ. Keratoconus. Cornea 1988;7:163-9.
8. Millin JA, Golub BM, Foster CS. Human basement membrane in keratoconus and normal corneas. Invest Ophthalmol Vis Sci 1986;27:604-7.
9. Tsuchiya S, Tanaka M, Konomi H, Hayashi T. Distribution of specific collagen types and fibronectin in normal and keratoconus corneas. Jpn J Ophthalmol 1986;30:14-31.
10. Nakayasu K, Tanaka M, Konomi H, Hayashi T. Distribution of types I, III, IV and V collagen in normal and keratoconus corneas. Ophthalmic Res 1986;18:1-10.
11. Morton K, Hutchinson C, Jeanny JC, Karpouzas I, Pouliquen Y, Courtois Y. Colocalization of fibroblast growth factor binding sites with extracellular matrix components in normal and keratoconus corneas. Curr Eye Res 1989;8:975-87.
12. Tuori A, Virtanen I, Aine E, Salminen I, Uusitalo M. Collagen types IV and VII in normal and keratoconus corneas. Invest Ophthalmol Vis Sci Suppl 1996;37:S92.
13. Hudson BG, Reeders ST, Tryggvason K. Type IV collagen: structure, gene organization, and role in human diseases. J Biol Chem 1993;268:26033-6.
14. Burgeson RE, Chiquet M, Deutzmann R, et al. A new nomenclature for the laminins. Matrix Biol 1994;14:209-11.
15. Ljubimov AV, Burgeson RE, Butkowski RJ, Michael AF, Sun T-T, Kenney MC. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest 1995;72:461-73.
16. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci 1996;37:997-1007.
17. Engvall E, Hessle H, Klier G. Molecular assembly, secretion, and matrix deposition of type VI collagen. J Cell Biol 1986;102:703-10.
18. Newsome DA, Foidart JM, Hassell JR, Krachmer JH, Rodrigues MM, Katz SI. Detection of specific collagen types in normal and keratoconus corneas. Invest Ophthalmol Vis Sci 1981;20:738-50.
19. Zimmermann DR, Fischer RW, Winterhalter KH, Witmer R, Vaughan L. Comparative studies of collagens in normal and keratoconus corneas. Exp Eye Res 1990;46:131-42.
20. Wessel H, Anderson S, Halvas E, Fite D, SundarRaj N. Type XII collagen-like protein is associated with transition of human limbal to corneal epithelium and stroma. Invest Ophthalmol Vis Sci Suppl 1995;36:S567.
21. Kato T, Nakayasu K, Kanai A, Nishiyama T, Hayashi T. Immunohistochemical localization of type XII collagen in the bovine cornea. Invest Ophthalmol Vis Sci Suppl 1996;37:S1009.
22. Zhan Q, Burrows R, Cintron C. Localization of type XII collagen in normal and healing rabbit cornea by in situ hybridization. Exp Eye Res 1995;60:551-61.
23. Cintron C, Hirano K, Kublin CL, Zhan Q. Immunohistochemistry of type XII collagen in the healing rabbit cornea. Invest Ophthalmol Vis Sci Suppl 1996;37:S1010.
24. Sawaguchi S, Yue BYJT, Sugar J, Gilboy JE. Lysosomal enzyme activities in keratoconus. Arch Ophthalmol 1989; 107:1507-10.
25. Fukuchi T, Yue BYJT, Sugar J, Lam S. Lysosomal enzyme activities in conjunctival tissues of patients with keratoconus. Arch Ophthalmol 1994;112:1368-74.
26. Fini ME, Yue BYJT, Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Curr Eye Res 1992;11:849-62.
27. Rehany U, Lahav M, Shoshan S. Collagenolytic activity in keratoconus. Ann Ophthalmol 1982;14:751-4.
28. Kao WW, Vergnes JP, Ebert J, Sundar-Raj CV, Brown SI. Increased collagenase and gelatinase activities in keratoconus. Biochem Biophys Res Commun 1982;107:929-36.
29. Kenney MC, Chwa M, Escobar M, Brown DJ. Altered gelatinolytic activity by keratoconus corneal cells. Biochem Biophys Res Commun 1989;161:353-7.
30. Kenney MC, Chwa M, Opbroek AJ, Brown DJ. Increased gelatinolytic activity in keratoconus keratocyte cultures: a correlation to an altered matrix metalloproteinase-2/tissue inhibitor of metalloproteinase ratio. Cornea 1994;13:114-24.
31. Yue BYJT, Lousin G, Sawaguchi S, Twining SS, Sugar J. Alpha-2-macroglobulin levels in keratoconus. Invest Ophthalmol Vis Sci Suppl 1992;33:S976.
32. Twining SS, Everse SJ, Wilson PM, Yue BYJT, Chan SK. Localization and quantification of an alpha-1-proteinase inhibitor in the human cornea. Curr Eye Res 1989;8:389-95.
33. Sawaguchi S, Twining SS, Yue BJT, Wilson PM, Sugar J, Chan SK. Alpha-1 proteinase inhibitor levels in keratoconus. Exp Eye Res 1990;50:549-54.
34. Brown DJ, Chwa MM, Opbroek A, Kenney MC. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors. Curr Eye Res 1993;12:571-81.
35. Opbroek A, Kenney MC, Brown DJ. Characterization of a human corneal metalloproteinase inhibitor. Curr Eye Res 1993;12:877-83.
36. Tuori A, Uusitalo H, Burgeson RE, Terttunen J, Virtanen I. The immunohistochemical composition of the human corneal basement membrane. Cornea 1996;15:286-94.
37. Chiquet-Ehrismann R. Tenascins, a growing family of extracellular matrix proteins. Experientia 1995;51:853-62.
38. Maguen E, Burgeson RE, Butkowski RJ, et al. Alterations of corneal extracellular matrix following multiple refractive procedures - a case report. Cornea (submitted).
39. Sugar J, Zhou L, Fukuchi T, Yue B. Expression of vimentin and tenascin in keratoconus corneas. Invest Ophthalmol Vis Sci Suppl 1994;35:S1358.
40. Tuori A, Virtanen I, Aine E, Salminen L, Uusitalo HM. Expression of tenascin in keratoconus and normal cornea. Invest Ophthalmol Vis Sci Suppl 1994;35:1358.
41. Ishizaki M, Westerhausen-Larson A, Kino J, Hayashi T, Kao WW-Y. Distribution of collagen IV in human ocular tissues. Invest Ophthalmol Vis Sci 1993;34:2680-9.
42. Wheatley HM, Traboulsi EI, Flowers BE, et al. Immunohistochemical localization of fibrillin in human ocular tissues: relevance to the Marfan syndrome. Arch Ophthalmol 1995;113:103-9.
43. Azar DT, Gipson IK. Immunolocalization of fibrillin and type VII collagen in keratoconus corneas. Invest Ophthalmol Vis Sci Suppl 1990;31:100.
44. Zaidi TS, Hasan A, Baum J, Panjwani N. Localization of fibrillin in normal human and bovine corneas. Invest Ophthalmol Vis Sci Suppl 1991;32:875.
45. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 1986;103:2499-509.
46. Wright DW, McDaniels CN, Swasdison S, Accavitti MA, Mayne PM, Mayne R. Immunization with undenatured bovine zonular fibrils results in monoclonal antibodies to fibrillin. Matrix Biol 1994;14:41-9.
47. Flowers CW, Chang KY, McLeod SD, et al. Changing indications for penetrating keratoplasty, 1983-1993. Cornea 1995;14:583-8.
48. Newsome DA, Hassell JR, Rodrigues MN, Rahe AE, Krachmer JH. Biochemical and histological analysis of "recurrent" macular corneal dystrophy. Arch Ophthalmol 1982;100:1125-31.